Quantitative Risk Evaluation of AdventitiousAgents in Heparin

Published 23 May 2023

John Raedts1, Edwin Kellenbach1

Address for correspondence John Raedts, PhD, Aspen Oss B.V., Kloosterstraat 6, P.O. Box 98, 5340 AB, Oss, The Netherlands (e-mail: jraedts@nl.aspenpharma.com).